#DOG 24.11.04. This month is cashed out. 24.10.31 late. The second largest part is the A-share medical consumption technology. The first is medicine, divided into innovative drugs, traditional Chinese medicine, and medical services. Innovative drugs: Huadong Medicine (hypoglycemic and medical beauty. Mamman's target), Lizhu A-share (Hong Kong stock connect), Fudan Zhangjiang (Hong Kong stock connect, Wang Ge thinks the decline is huge), Shenzhou Cells, Haichuang Pharmaceutical. Tebao Biotech (target 200 yuan. Bottom up ten times, good performance, good performance in the next two or three year